Press Releases

DZIF news and press releases at a glance

Tuberculosis patients
© Christoph Lange

Tuberculosis: Different types of immunity determine the course of the disease

An international research team has succeeded in characterising different immune responses of tuberculosis patients and identifying groups of patients who either showed a very low or a very strong

Louisa Ruhl und Christine Falk
© MHH/K.Kaiser

How a SARS-CoV-2 infection can become severe COVID-19

Infection with SARS-CoV-2 leaves some people almost unaffected, while others develop life-threatening COVID-19 symptoms. So far, we do not understand exactly why symptoms and disease severity

Blood culture bottles in incubator
© DZIF/scienceRELATION

Novel prediction model for mortality in blood stream infections developed

Bloodstream infections (BSI) are serious bacterial infections associated with high mortality. A research team developed the clinical BLOOMY* scores in order to identify risk factors and thus be able

Hepatitis C with antibody
© Timm Weber

Characterisation of broadly neutralising antibodies against the hepatitis C virus

Despite improved methods of treatment, an infection with the hepatitis C virus still leads to approximately 400,000 deaths worldwide each year. The development of a vaccine is urgently required, but

EBV-Viren in Zellen
© CDC/Dr. P. Feorino

Epstein-Barr virus: DZIF and Helmholtz Munich working on a vaccine

The Epstein-Barr virus (EBV) has been known for some time to play a part in a range of diseases. A current US study has now shown a close link between EBV and multiple sclerosis. DZIF scientists at

Jetzt für den DZIF-Presseverteiler anmelden

Erhalten Sie die Pressemitteilungen des DZIF direkt in Ihren Posteingang.